相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 询价记录
- 文献和实验
- 技术资料
- 抗体英文名:
p44/42 MAPK (Erk1/2) Antibody
- 抗原:
synthetic peptide corresponding to a sequence in the C-terminus of rat p44 MAP Kinase
- 应用范围:
W, IP, IHC-P, IF-IC, F
- 宿主:
Rabbit
- 适应物种:
H,M,R,Hm,Mk,Mi,Z,B,Pg,Sc
- 库存:
大量
- 供应商:
CST
- 保质期:
详见说明书
- 级别:
详见MSDS文件
- 是否单克隆:
2
- 保存条件:
-20°c
- 规格:
200 ul (20 western blots)/600 ul (60 western blots)/carrier free & custom formulation / quantity
| 规格: | 产品价格: | ¥请询价 | |
|---|---|---|---|
| 规格: | 200 ul (20 western blots) | 产品价格: | ¥请询价 |
| 规格: | 600 ul (60 western blots) | 产品价格: | ¥请询价 |
| 规格: | carrier free & custom formulation / quantity | 产品价格: | ¥请询价 |
pathway more info application references datasheet PDF MSDS PDF protocols
Applications Key: W=Western Blotting IP=Immunoprecipitation IHC-P=Immunohistochemistry (Paraffin) IF-IC=Immunofluorescence (Immunocytochemistry) F=Flow Cytometry
Reactivity Key: H=Human M=Mouse R=Rat Hm=Hamster Mk=Monkey Mi=Mink Z=Zebrafish B=Bovine Pg=Pig Sc=S. cerevisiae
Species cross-reactivity is determined by western blot. Species enclosed in parentheses are predicted to react based on 100% sequence homology.
| Applications | Reactivity | Sensitivity | MW (kDa) | Source |
|---|---|---|---|---|
| W IP IHC-P IF-IC F | H M R Hm Mk Mi Z B Pg Sc | Endogenous | 42, 44 | Rabbit |
| Protocols |
|
|---|---|
| Specificity / Sensitivity | p44/42 MAPK (Erk1/2) Antibody detects endogenous levels of total p44/42 MAP kinase (Erk1/Erk2) protein. In some cell types, this antibody recognizes p44 MAPK more readily than p42 MAPK. The antibody does not recognize either JNK/SAPK or p38 MAP kinase. |
| Source / Purification | Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to a sequence in the C-terminus of rat p44 MAP Kinase. Antibodies are purified by protein A and peptide affinity chromatography. Western Blotting
Western blot analysis of extracts from HeLa cells transfected with 100 nM control siRNA #6201 (-) or p44 MAPK (Erk1) siRNA (+), using p44/42 MAPK (Erk1/2) Antibody #9102 and GCK Antibody #3782. The Erk1/2 antibody confirms silencing of Erk1 expression, and GCK Antibody is used to control for loading and specificity of p44 MAPK (Erk1) siRNA. Western Blotting
Western blot analysis of extracts from serum-induced PC12 cells, using Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) Antibody #9101 (upper) or control p44/42 MAPK (Erk1/2) Antibody (lower). IHC-P (paraffin)
Immunohistochemical analysis of paraffin-embedded human breast carcinoma, showing nuclear and cytoplasmic localization, using p44/42 MAPK (Erk1/2) Antibody. Flow Cytometry
Flow cytometric analysis of Jurkat cells, using p44/42 MAPK (Erk1/2) Antibody (blue) compared to a nonspecific negative control antibody (red). IF-IC
Confocal immunofluorescent images of C6 cells serum-starved (left) and serum-treated (center), labeled with p44/42 MAPK (Erk1/2) Antibody (green) compared to an isotype control (right). Actin filaments have been labeled with Alex Fluor® 555 phalloidin. Blue pseudocolor = DRAQ5® #4084 (fluorescent DNA dye). |
| Background | Mitogen-activated protein kinases (MAPKs) are a widely conserved family of serine/threonine protein kinases involved in many cellular programs such as cell proliferation, differentiation, motility, and death. The p44/42 MAPK (Erk1/2) signaling pathway can be activated in response to a diverse range of extracellular stimuli including mitogens, growth factors, and cytokines (1-3) and is an important target in the diagnosis and treatment of cancer (4). Upon stimulation, a sequential three-part protein kinase cascade is initiated, consisting of a MAP kinase kinase kinase (MAPKKK or MAP3K), a MAP kinase kinase (MAPKK or MAP2K), and a MAP kinase (MAPK). Multiple p44/42 MAP3Ks have been identified, including members of the Raf family, as well as Mos and Tpl2/Cot. MEK1 and MEK2 are the primary MAPKKs in this pathway (5,6). MEK1 and MEK2 activate p44 and p42 through phosphorylation of activation loop residues Thr202/Tyr204 and Thr185/Tyr187, respectively. Several downstream targets of p44/42 have been identified, including p90RSK (7) and the transcription factor Elk-1 (8,9). p44/42 are negatively regulated by a family of dual-specificity (Thr/Tyr) MAPK phosphatases, known as DUSPs or MKPs (10), along with MEK inhibitors such as U0126 and PD98059.
|
| Application References |
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know ! |
| Companion Products |
For Research Use Only. Not For Use In Diagnostic Procedures. |
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
- 作者
- 内容
- 询问日期
文献和实验Study of MAPK Signaling Using Knockout Mice
The p42 and p44 mitogen-activated protein kinases (MAPKs) (p42/p44 MAPK, Erk2 /Erk1) are activated through the small G protein Ras and sequential activation of the protein kinases Raf and MEK on stimulation of cells with a broad range
转导通路调控细胞生长和分化,JNK和p38 MAPK信号转导通路在炎症与细胞凋亡等应激反应中发挥重要作用。使用这一芯片试剂盒检测RNA实验标本,操作者通过杂交反应技术,即可研究实验系统中与MAPK信号通路相关基因表达水平改变。 MAPK属于一种Ser/Thr蛋白激酶,可在多种不同的信号转导途径中充当一种共同的信号转导成份,且在细胞周期 调控中发挥重要的作用。目前MAPK家族中至少有4个成员已被纯化和深入 研究。如p42mapk,p44erk1,p54MAPK及p44mpk。
蛋白Ras的GDP解离而结合GTP,从而激活Ras;激活的Ras进一步与丝/苏氨酸蛋白激酶Raf-1的氨基端结合,通过未知机制激活Raf-1;Raf-1可磷酸化MEK1/MEK2(MAP kinase/ERK kinase)上的二个调节性丝氨酸,从而激活MEKs;MEKs为双特异性激酶,可以使丝/苏氨酸和酪氨酸发生磷酸化,最终高度选择性地激活ERK1和ERK2(即p44MAPK和p42MAPK)。ERKs为脯氨酸导向的丝/苏氨酸激酶,可以磷酸化与脯氨酸相邻的丝/苏氨酸。在丝裂原刺激后,ERKs接受上游
技术资料暂无技术资料 索取技术资料







